Effectiveness of fibrin sealants in reducing blood drainage after total knee arthroplasty

doi:10.3969/j.issn.2095-4344.2013.13.017

Abstract

Abstract:

BACKGROUND: There is no systematic evaluation about effectiveness and safety of fibrin sealants in reducing blood drainage after total knee arthroplasty.
OBJECTIVE: To systematically evaluate the effectiveness and safety of fibrin sealants in reducing blood drainage after total knee arthroplasty.
METHODS: A computer-based search was performed in PubMed database, Cochrane Library, EMBASE database, OVID database, China Journal Full-text database, Chinese Biomedicine database and Chinese Scientific Journals Full-text database for randomized controlled trials from 1975 to October 2012 and manual search was performed in the relevant orthopedic journals. The Chinese key words were “total knee arthroplasty, knee joint replacement, fibrin sealants, tissue glue”. The quality of the extracted data was evaluated by Jadad methodological assessment, and Revman 5.1 software was used for the statistical analysis. The blood drainge, rate of transfusion, the average hospital stay, range of motion of knee joint and the rate of deep vein thrombosis after total knee arthroplasty were observed.
RESULTS AND CONCLUSION: A total of 310 cases in five clinical prospective randomized controlled trials were included. Totally 168 patients were enrolled in the fibrin sealants group and 142 in the control group. Meta-analysis results showed that fibrin sealants could reduce the amount of blood drainage significantly in fibrin sealant group [weighted mean difference (MD)=-386.88, 95% confidence interval (CI): -583.66-, -190.10, P < 0.01]; moreover, the rate of transfusion in fibrin sealants group was significantly lower than that in the control group [relative risk (RR)=0.53, 95%CI: 0.42, 0.83, P < 0.01]. Fibrin sealants could reduce the average hospital stay in fibrin sealant group (MD=-3.56, 95%CI: -4.97-2.16, P < 0.01), meanwhile, it could improve the range of motion of knee joint in fibrin sealant group (MD=16.48, 95%CI: 5.94-27.02, P < 0.01). There was no significant difference of deep vein thrombosis between two groups (RR=1.18, 95%CI: 0.18-7.84, P=0.86). The results indicated that fibrin sealants could significantly reduce the blood drainage and rate of transfusion after total knee arthroplasty and had a good hemostatic effect, but there was still no evidence that the fibrin sealants could increase the incidence of deep vein thrombosis.

Key words: bone and joint implants, evidence-based medicine of bone and joint implants, total knee replacement, fibrin sealants, randomized controlled trials, drainage volume, transfusion rate, high range of motion of knee joint, deep vein thrombosis, Meta-analysis

CLC Number:

R318

Yang Li-yu, Wang Xing-li, Zhou Long, Xue Feng, Ba Gen, Fu Qin. Effectiveness of fibrin sealants in reducing blood drainage after total knee arthroplasty[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(13): 2399-2406.

Figures/Tables 9

References

[1] Lotke PA, Faralli VJ, Orenstein EM, et al. Blood loss after total knee replacement: effect of tourniquet release and continuous passive motion. J Bone Joint Surg Am. 1991;73(7):1037- 1040.

[2] Jackson MR, MacPhee MJ, Drohan WN, et al. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis. 1996;7(8):737-746.

[3] Radosevich M, Goubran HA, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang. 1997;72(3):133-143.

[4] Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials. 1996;17(1):1-12.

[5] Sabatini L, Trecci A, Imarisio D, et al. Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol. 2012;13(3):145-151.

[6] Levy O, Martinowitz U, Oran A, et al. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am.1999; 81(11):1580-1588.

[7] Kluba T, Fiedler K, Kunze B, et al. Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty. Arch Orthop Trauma Surg. 2012;132(8):1147-1152.

[8] Notarnicola A, Moretti L, Martucci A, et al. Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis. 2012; 23(4):278-284.

[9] Molloy DO, Archbold HA, Ogonda L, et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br. 2007;89(3):306-309.

[10] McConnell JS, Shewale S, Munro NA, et al. Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee. 2012;19(4):295-298.

[11] Wang GJ, Hungerford DS, Savory CG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001;83(10): 1503-1505.

[12] Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am.1999;81(1):2-10.

[13] Padala PR, Rouholamin E, Mehta RL. The role of drains andtourniquets in primary total knee replacement: a comparative study of TKR performed with drains and tourniquet versus no drains and adrenaline and saline infiltration. J Knee Surg. 2004;17(1):24-27.

[14] Helm AT, Karski MT, Parsons SJ, et al. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br. 2003;85(4):484-489.

[15] Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br. 2008;90(9): 112-1136.

[16] Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med. 2007;131(5):695-701.

[17] Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic surgery transfusion hemoglobin european overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43(4):459-469.

[18] Hill GE, Frawley WH, Griffith KE, et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54(5):908-914.

[19] Everts PA, Devilee RJ, Oosterbos CJ, et al. Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc. 2007;15(7):888-894.

[20] Bernasek TL, Burris RB, Fujii H, et al. Effect on blood loss and cost-effectiveness of pain cocktails, platelet-rich plasma, or fibrin sealant after total knee arthroplasty. J Arthroplasty. 2012; 27(8):1448-1451.

[21] Steuten L, Vallejo-Torres L, Bastide P, et al. Analysing uncertainty around costs of innovative medical technologies: the case of fibrin sealant (QUIXIL) for total knee replacement. Health Policy. 2009;89(1):46-57.

[22] Thoms RJ, Marwin SE. The role of fibrin sealants in orthopaedic surgery. J Am Acad Orthop Surg. 2009;17(12): 727-736.

[23] Alshryda S, Sarda P, Sukeik M, et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011;93(12):1577-1585.